Skip to content

Nasdaq · CIK 0001736730

CAMP Camp4 Therapeutics Corp

Insider trading from SEC Form 4. Last filing 40 d ago. Close $3.77 on Oct 9, 2026, +30% from the 52-week low and -47% from the high.

Last 90 days

Net insider value
+$40k
more bought than sold
Buys
1
$40k by 1 insider
Sells
0
$0 by 0 insiders
Insiders on file
19
with a Form 4 at this company

Price and insider trades, last year

CAMPOct 9, 2026 · close 3.77

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Camp4 Therapeutics Corp, scored.

ScoreInsiderValueHoldingsPrice contextFiled
44ModerateKelly Gold
Chief Financial Officer
buy
$40k
10,000 shares
-+181% from low-44% from high
63Notable5AM Partners VI, LLC
owner
buy
$4.5M
2,941,176 shares
-+106% from low-76% from high
73NotableAmir Nashat
director, owner
buy
$2.0M
1,307,189 shares
+82%+106% from low-76% from high
65NotablePolaris Management Co. VII, L.L.C.
owner
buy
$2.0M
1,307,189 shares
+82%+106% from low-76% from high
41ModerateRichard A Young
director
buy
$25k
15,151 shares
+10%+106% from low-76% from high
46ModerateYuri Maricich
Chief Medical Officer
buy
$9,999
6,060 shares
-+106% from low-76% from high
48ModerateJosh Mandel-Brehm
Chief Executive Officer
buy
$9,999
6,060 shares
+2%+106% from low-76% from high
48ModerateKelly Gold
Chief Financial Officer
buy
$9,999
6,060 shares
+10%+106% from low-76% from high
55ModeratePolaris Management Co. VII, L.L.C.
owner
buy
$10.0M
909,090 shares
-+10% from low0% from high
57ModerateAH Equity Partners Bio I, L.L.C.
owner
buy
$8.0M
727,272 shares
+52%+10% from low0% from high
57ModerateEnavate Sciences GP, LLC
owner
buy
$15M
1,363,636 shares
+56%+10% from low0% from high
55ModerateNorthpond Ventures II GP, LLC
owner
buy
$8.4M
763,636 shares
-+10% from low0% from high
57Moderate5AM Partners VI, LLC
owner
buy
$10.0M
909,090 shares
+53%+10% from low0% from high
55ModeratePolaris Management Co. VII, L.L.C.
owner
buy
$10.0M
909,090 shares
-+10% from low0% from high
65NotableAndrew J. Schwab
director, owner
buy
$10.0M
909,090 shares
+53%+10% from low0% from high
63NotableAmir Nashat
director, owner
buy
$10.0M
909,090 shares
-+10% from low0% from high

Transactions

The last 84 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Aug 31, 2026Kelly Gold
Chief Financial Officer
POpen-market purchase
Common Stockindirect: By Spouse
+10,000$3.96$40k10,00040 d ago
Sep 11, 20255AM Partners VI, LLC
owner
POpen-market purchase
Common Stockindirect: By 5AM Ventures VII, L.P.
+2,941,176$1.53$4.5M2,941,176Sep 15, 2025
Sep 11, 2025Andrew J. Schwab
director, owner
AGrant or award
Common Stockindirect: By 5AM Ventures VII, L.P.
+2,941,176$1.53$4.5M2,941,176Sep 15, 2025
Sep 11, 2025Amir Nashat
director, owner
POpen-market purchase
Common Stockindirect: See Footnote
+1,221,721$1.53$1.9M2,825,500Sep 11, 2025
Sep 11, 2025Polaris Management Co. VII, L.L.C.
owner
POpen-market purchase
Common Stockindirect: See footnote
+1,221,721$1.53$1.9M2,825,500Sep 11, 2025
Sep 11, 2025Richard A Young
director
POpen-market purchase
Common Stock
+15,151$1.65$25k170,010Sep 11, 2025
Sep 11, 2025Yuri Maricich
Chief Medical Officer
POpen-market purchase
Common Stock
+6,060$1.65$9,9996,060Sep 11, 2025
Sep 11, 2025Josh Mandel-Brehm
Chief Executive Officer
POpen-market purchase
Common Stock
+6,060$1.65$9,999278,417Sep 11, 2025
Sep 11, 2025Kelly Gold
Chief Financial Officer
POpen-market purchase
Common Stock
+6,060$1.65$9,99967,877Sep 11, 2025
Sep 11, 2025Amir Nashat
director, owner
POpen-market purchase
Common Stockindirect: See Footnote
+85,468$1.53$131k197,661Sep 11, 2025
Sep 11, 2025Polaris Management Co. VII, L.L.C.
owner
POpen-market purchase
Common Stockindirect: See footnote
+85,468$1.53$131k197,661Sep 11, 2025
Jun 25, 2025Michael J Higgins
director
AGrant or award
Stock Option (Right to Buy)derivative
+9,000$0.00$09,000Jun 27, 2025
Jun 25, 2025Richard A Young
director
AGrant or award
Stock Option (Right to Buy)derivative
+9,000$0.00$09,000Jun 27, 2025
Jun 25, 2025Andrew J. Schwab
director, owner
AGrant or award
Stock Option (Right to Buy)derivative
+9,000$0.00$09,000Jun 27, 2025
Jun 25, 2025Steven H Holtzman
director
AGrant or award
Stock Option (Right to Buy)derivative
+9,000$0.00$09,000Jun 27, 2025
Jun 25, 2025Ravi I. Thadhani
director
AGrant or award
Stock Option (Right to Buy)derivative
+9,000$0.00$09,000Jun 27, 2025
Jun 25, 2025James P Boylan
director
AGrant or award
Stock Option (Right to Buy)derivative
+9,000$0.00$09,000Jun 27, 2025
Jun 25, 2025Paula Ragan
director
AGrant or award
Stock Option (Right to Buy)derivative
+9,000$0.00$09,000Jun 27, 2025
Jun 25, 2025Amir Nashat
director, owner
AGrant or award
Stock Option (Right to Buy)derivative
+9,000$0.00$09,000Jun 27, 2025
Apr 1, 2025David Bumcrot
Chief Scientific Officer
AGrant or award
Stock Option (Right to Buy)derivative
+45,000$0.00$045,000Apr 3, 2025
Apr 1, 2025Josh Mandel-Brehm
Chief Executive Officer
AGrant or award
Stock Option (Right to Buy)derivative
+160,000$0.00$0160,000Apr 3, 2025
Apr 1, 2025Kelly Gold
Chief Financial Officer
AGrant or award
Stock Option (Right to Buy)derivative
+80,000$0.00$080,000Apr 3, 2025
Apr 1, 2025Yuri Maricich
Chief Medical Officer
AGrant or award
Stock Option (Right to Buy)derivative
+80,000$0.00$080,000Apr 3, 2025
Mar 17, 2025Douglas E Williams
director
AGrant or award
Stock Option (Right to Buy)derivative
+17,787$0.00$017,787Mar 19, 2025
Mar 17, 2025Murray Stewart
director
AGrant or award
Stock Option (Right to Buy)derivative
+17,787$0.00$017,787Mar 19, 2025
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Common Stockindirect: See footnote
+1,250,061--1,250,061Oct 22, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Common Stockindirect: See footnote
+87,448--87,448Oct 22, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Common Stockindirect: See footnote
+353,718--1,603,779Oct 22, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Common Stockindirect: See footnote
+24,745--112,193Oct 22, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
POpen-market purchase
Common Stockindirect: See footnote
+909,090$11.00$10.0M909,090Oct 22, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Series A Prime Preferred Stockderivativeindirect: See Footnote
-14,020,475--0Oct 22, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Series A Prime Preferred Stockderivativeindirect: See Footnote
-980,829--0Oct 22, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Series B Preferred Stockderivativeindirect: See Footnote
-3,967,234--0Oct 22, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Series B Preferred Stockderivativeindirect: See Footnote
-277,536--0Oct 22, 2024
Oct 15, 2024AH Equity Partners Bio I, L.L.C.
owner
CConversion
Common Stockindirect: By AH Bio Fund I, L.P., as nominee
+1,398,067--1,398,067Oct 17, 2024
Oct 15, 2024Northpond Ventures II GP, LLC
owner
CConversion
Common Stockindirect: By Northpond Ventures II, LP
+1,003,193--1,003,193Oct 17, 2024
Oct 15, 2024Enavate Sciences GP, LLC
owner
CConversion
Common Stockindirect: By Everest Aggregator, LP
+2,422,166--2,422,166Oct 17, 2024
Oct 15, 2024AH Equity Partners Bio I, L.L.C.
owner
POpen-market purchase
Common Stockindirect: By AH Bio Fund I, L.P., as nominee
+181,818$11.00$2.0M1,579,885Oct 17, 2024
Oct 15, 2024Northpond Ventures II GP, LLC
owner
CConversion
Common Stockindirect: By Northpond Ventures, LP
+471,415--471,415Oct 17, 2024
Oct 15, 2024Enavate Sciences GP, LLC
owner
POpen-market purchase
Common Stockindirect: By Everest Aggregator, LP
+1,363,636$11.00$15M3,785,802Oct 17, 2024
Oct 15, 2024AH Equity Partners Bio I, L.L.C.
owner
POpen-market purchase
Common Stockindirect: By AH Bio Fund IV, L.P., as nominee
+545,454$11.00$6.0M545,454Oct 17, 2024
Oct 15, 2024Northpond Ventures II GP, LLC
owner
POpen-market purchase
Common Stockindirect: By Northpond Ventures III, LP
+763,636$11.00$8.4M763,636Oct 17, 2024
Oct 15, 2024Enavate Sciences GP, LLC
owner
CConversion
Series B Preferred Stockderivativeindirect: By Everest Aggregator, LP
-27,166,530--0Oct 17, 2024
Oct 15, 2024AH Equity Partners Bio I, L.L.C.
owner
CConversion
Series A Prime Preferred Stockderivativeindirect: By AH Bio Fund I, L.P., as nominee
-15,001,312--0Oct 17, 2024
Oct 15, 2024Northpond Ventures II GP, LLC
owner
CConversion
Series A Prime Preferred Stockderivativeindirect: By Northpond Ventures II, LP
-11,251,624--0Oct 17, 2024
Oct 15, 2024AH Equity Partners Bio I, L.L.C.
owner
CConversion
Series B Preferred Stockderivativeindirect: By AH Bio Fund I, L.P., as nominee
-679,163--0Oct 17, 2024
Oct 15, 2024Northpond Ventures II GP, LLC
owner
CConversion
Series B Preferred Stockderivativeindirect: By Northpond Ventures, LP
-5,287,303--0Oct 17, 2024
Oct 15, 20245AM Partners VI, LLC
owner
CConversion
Common Stockindirect: By 5AM Ventures VI, L.P.
+1,716,055--1,716,055Oct 15, 2024
Oct 15, 2024Amir Nashat
director, owner
CConversion
Common Stockindirect: See Footnote
+1,250,061--1,250,061Oct 15, 2024
Oct 15, 2024Andrew J. Schwab
director, owner
CConversion
Common Stockindirect: See Footnote
+1,337,592--1,337,592Oct 15, 2024
Oct 15, 2024Richard A Young
director
CConversion
Common Stock
+8,917--154,859Oct 15, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Common Stockindirect: See footnote
+1,250,061--1,250,061Oct 15, 2024
Oct 15, 2024Josh Mandel-Brehm
Chief Executive Officer
CConversion
Common Stock
+605--272,357Oct 15, 2024
Oct 15, 2024Steven H Holtzman
director
CConversion
Common Stock
+8,917--108,946Oct 15, 2024
Oct 15, 2024Josh Mandel-Brehm
Chief Executive Officer
CConversion
Series B Preferred Stockderivative
-6,791--0Oct 15, 2024
Oct 15, 20245AM Partners VI, LLC
owner
CConversion
Common Stockindirect: By 5AM Opportunities II, L.P.
+302,770--302,770Oct 15, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Common Stockindirect: See footnote
+87,448--87,448Oct 15, 2024
Oct 15, 2024Andrew J. Schwab
director, owner
CConversion
Common Stockindirect: See Footnote
+378,463--1,716,055Oct 15, 2024
Oct 15, 2024Steven H Holtzman
director
CConversion
Series A Prime Preferred Stockderivative
-100,014--0Oct 15, 2024
Oct 15, 2024Amir Nashat
director, owner
CConversion
Common Stockindirect: See Footnote
+87,448--87,448Oct 15, 2024
Oct 15, 2024Richard A Young
director
CConversion
Series A Prime Preferred Stockderivative
-100,014--0Oct 15, 2024
Oct 15, 2024Amir Nashat
director, owner
CConversion
Common Stockindirect: See Footnote
+353,718--1,603,779Oct 15, 2024
Oct 15, 20245AM Partners VI, LLC
owner
POpen-market purchase
Common Stockindirect: By 5AM Ventures VI, L.P.
+909,090$11.00$10.0M2,625,145Oct 15, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Common Stockindirect: See footnote
+353,718--1,603,779Oct 15, 2024
Oct 15, 2024Andrew J. Schwab
director, owner
CConversion
Common Stockindirect: See Footnote
+302,770--302,770Oct 15, 2024
Oct 15, 2024Andrew J. Schwab
director, owner
POpen-market purchase
Common Stockindirect: See Footnote
+909,090$11.00$10.0M2,625,145Oct 15, 2024
Oct 15, 20245AM Partners VI, LLC
owner
CConversion
Series A Prime Preferred Stockderivativeindirect: By 5AM Ventures VI, L.P.
-15,002,166--0Oct 15, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Common Stockindirect: See footnote
+24,745--112,193Oct 15, 2024
Oct 15, 2024Amir Nashat
director, owner
CConversion
Common Stockindirect: See Footnote
+24,745--112,193Oct 15, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
POpen-market purchase
Common Stockindirect: See footnote
+909,090$11.00$10.0M909,090Oct 15, 2024
Oct 15, 20245AM Partners VI, LLC
owner
CConversion
Series B Preferred Stockderivativeindirect: By 5AM Ventures VI, L.P.
-4,244,770--0Oct 15, 2024
Oct 15, 2024Amir Nashat
director, owner
POpen-market purchase
Common Stockindirect: See Footnote
+909,090$11.00$10.0M909,090Oct 15, 2024
Oct 15, 2024Andrew J. Schwab
director, owner
CConversion
Series A Prime Preferred Stockderivativeindirect: See Footnote
-15,002,166--0Oct 15, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Series A Prime Preferred Stockderivativeindirect: See Footnote
-14,020,475--0Oct 15, 2024
Oct 15, 2024Andrew J. Schwab
director, owner
CConversion
Series B Preferred Stockderivativeindirect: See Footnote
-4,244,770--0Oct 15, 2024
Oct 15, 20245AM Partners VI, LLC
owner
CConversion
Series B Preferred Stockderivativeindirect: By 5AM Opportunities II, L.P.
-3,395,816--0Oct 15, 2024
Oct 15, 2024Amir Nashat
director, owner
CConversion
Series A Prime Preferred Stockderivativeindirect: See Footnote
-14,020,475--0Oct 15, 2024
Oct 15, 2024Andrew J. Schwab
director, owner
CConversion
Series B Preferred Stockderivativeindirect: See Footnote
-3,395,816--0Oct 15, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Series A Prime Preferred Stockderivativeindirect: See Footnote
-980,829--0Oct 15, 2024
Oct 15, 2024Amir Nashat
director, owner
CConversion
Series A Prime Preferred Stockderivativeindirect: See Footnote
-980,829--0Oct 15, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Series B Preferred Stockderivativeindirect: See Footnote
-3,967,234--0Oct 15, 2024
Oct 15, 2024Amir Nashat
director, owner
CConversion
Series B Preferred Stockderivativeindirect: See Footnote
-3,967,234--0Oct 15, 2024
Oct 15, 2024Amir Nashat
director, owner
CConversion
Series B Preferred Stockderivativeindirect: See Footnote
-277,536--0Oct 15, 2024
Oct 15, 2024Polaris Management Co. VII, L.L.C.
owner
CConversion
Series B Preferred Stockderivativeindirect: See Footnote
-277,536--0Oct 15, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

CAMP insider trading: Camp4 Therapeutics Corp | InsiderTell